A New Shot Guards Against H.I.V., but Access for Africans Is Uncertain 

Biden’s Omicron Booster Campaign Faces Fatigue, Efficacy Doubts 

Moderna Patent Strike on Pfizer Sets Up Post-Covid Vaccine Feuds 

The HIV prevention drug that could save millions of people – if they can afford it 

Just six injections a year can prevent HIV: here’s what it will take for the world to afford them 

AIDS activists are going after Biden on his monkeypox response 

Activists Disrupt Global AIDS Conference to Demand Action on Monkeypox 

Pharma deal gives 90 countries access to cheaper HIV prevention injection 

Pharma Deal Enables 90 Countries to get Access to Cheaper HIV Prevention Injectable 

ViiV to Allow Generics of Its Long-Acting Injectable PrEP to Prevent HIV 

ViiV Healthcare to allow 90 countries to access generic versions of HIV prevention shot 

A ViiV deal to license its HIV prevention shot to poor countries runs into criticism 

Biden Told Not to Give Publicly Owned Covid-19 Vaccine Tech Over to Corporations 

Pharma and patient advocates offer competing visions for achieving vaccine equity during pandemics 

The Spectacular Failure of the WTO To fight Covid 

Brook Baker Reacts to WTO TRIPS Decision (5:10) 

WHO to Share Vaccines to Stop Monkeypox Amid Inequity Fears 

Maryland-based Novavax has sent millions of COVID vaccine doses to wealthy nations and none to the initiative ... 

ViiV will make it easier for generic companies to copy its HIV prevention shot, but it’s not clear when 

ViiV ‘actively negotiating’ voluntary licence for HIV prevention drug 

SEE MORE